New CRISPR-based antiviral shows broad protection against respiratory viruses in preclinical studies
A CRISPR-based antiviral platform has advanced through preclinical testing with promising breadth and potency. Researchers report protection against multiple respiratory viruses in cell cultures and animal models. The approach targets…
